Molecular Markers in Breast Ductal Carcinoma In SituMolecular Markers in Breast Ductal Carcinoma In Situ
Next-generation sequencing is an exciting new tool for discovering novel potential therapeutic targets and candidate biomarkers in breast cancer, particularly ductal carcinoma in situ. Expert Review of Molecular Diagnostics
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Pathology & Lab Medicine Journal Article Source Type: news
More News: Breast Cancer | Breast Carcinoma | Cancer | Cancer & Oncology | Carcinoma | Carcinoma in Situ | DCIS (Ductal Carcinoma in Situ) | Ductal Carcinoma | Health | Pathology